Stifel Nicolaus analyst Chad Vanacore reiterated a Buy rating on HCP Inc (NYSE: HCP) yesterday and set a price target of $28. The company’s shares closed yesterday at $26.46.
Vanacore has an average return of 16.3% when recommending HCP Inc.
According to TipRanks.com, Vanacore is ranked #2594 out of 4848 analysts.
Currently, the analyst consensus on HCP Inc is a Moderate Buy with an average price target of $27.25.
See today’s analyst top recommended stocks >>
The company has a one-year high of $30.59 and a one-year low of $21.48. Currently, HCP Inc has an average volume of 3.33M.
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HCP in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HCP, Inc. is a real estate investment trust which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers.
